CareChoice Homecare Ranked #33 Among Greater Philadelphia's 272 Most Impactful Employers PHILADELPHIA, PA / ACCESS Newswire / November 18, 2025 / CareChoice is proud to announce its inclusion in the ...
LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 18, 2025 / As we observe National Diabetes Month, St. Joseph Medical is proud to highlight some of the inspiring journeys of patients who have ...
A Colorado surgeon's groundbreaking reconstruction rebuilds a child's eyelids, rescues her sight, and transforms a once-hopeless diagnosis into a life filled with possibility and a second chance at ...
ClinChoice is proud to announce the successful completion and approval of its ISO 9001:2015 and ISO 14155:2020 ...
First-of-a-kind health economics study found lifetime per-patient savings from early TAVR range from £1,788 in the UK to CHF ...
A North Wales pharmaceutical manufacturer backed by the Development Bank of Wales is accelerating its global expansion by launching two new products and unveiling plans to extend its global ...
EXTON, PA / ACCESS Newswire / November 18, 2025 / AideChoice, a pioneering app-based platform connecting individuals with trusted short-term non-medical home care services, today announced its ...
The new in-network contract further supports The Ridge RTC’s commitment to affordable and accessible mental health care at its treatment programs in Maine and New Hampshire MILTON, NH / ACCESS ...
Is a Serious, Progressive Lung Disease That Can Lead to Permanent Lung Damage[i] — BRINSUPRI Is a First-in-Disease, First-in-Class DPP1 Inhibitor Targeting Neutrophilic Inflammation — BRINSUPRI Was ...
Total capital raised across Sofinnova’s platform reaches €1.5Bn over the past yearSofinnova Capital XI is actively investing in early-stage biotech and medtech companies across Europe and the USPARIS, ...
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical ...
BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of a new Business Unit (BU) dedicated to advancing peptide drug discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results